The Potential Declining Efficacy of the ChAdOx1 nCoV-19 Vaccine (AZD1222) on Inoculators With Nonsteroidal Anti-inflammatory Drug (NSAID) Intake

Clin Infect Dis. 2022 Mar 1;74(4):753-754. doi: 10.1093/cid/ciab516.

Author

Hsin-Fu Yeh^{1

2}

Affiliations

¹ Department of Family Medicine, St. Martin De Porres Hospital, Chiayi, Taiwan.
² National Yang-Ming University, Institute of Traditional Medicine, Taipei, Taiwan.

PMID: 34079995
DOI: 10.1093/cid/ciab516

No abstract available

Publication types

Letter

MeSH terms

Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
COVID-19 Vaccines
COVID-19* / prevention & control
ChAdOx1 nCoV-19*
Humans

Substances

Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
COVID-19 Vaccines
ChAdOx1 nCoV-19